Targeted mechanical stimulation to release fascial restrictions, optimize tissue glide, and leverage natural endothelial nitric oxide signaling.
Fascia is a continuous connective-tissue network surrounding muscles, tendons, ligaments, nerves, blood vessels, and joints.
When fascial layers become restricted, normal tissue glide and force transmission are reduced. NOR places specific fascial pathways under controlled tensile load to improve extensibility and restore movement between adjacent tissues.
The term release refers to decreased restrictive tension and improved tissue excursion.
Nitric oxide is a naturally occurring gaseous signaling molecule involved in vascular regulation, circulation, cellular communication, neuromuscular function, and tissue recovery.
Nitric oxide, or NO, is a short-lived gas produced naturally within endothelial, neural, muscular, and immune tissues. In the vascular system, nitric oxide activates the NO–cGMP pathway, producing smooth-muscle relaxation and vasodilation. This supports regional blood flow, microcirculation, oxygen delivery, and tissue perfusion.
NOR does not introduce nitric oxide into the body. The controlled stretching used in NOR provides mechanical stimulation that supports the body’s normal nitric oxide response.
NOR is performed before advanced Dynamic Release procedures to improve both the mechanical and physiological condition of the tissue. It prepares the patient for:
Prepare. Release. Restore. Perform.
Join an upcoming DRT seminar and learn NOR alongside the full DRT system.
